Bellicum Pharma (BLCM) Misses Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Join SI Premium – FREE
Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.63), $0.19 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
